Abbreviations: CCK , cholecystokinin; CDK2, cyclin-dependent kinase 2; DMEM, Dulbecco's Modified Eagle Medium; HBS, HEPES buffered saline; SFK, Src-family tyrosine kinases. ions can regulate SFK activity by binding to the phosphorylated C-terminal regulatory tyrosine.
Introduction
The ability to phosphorylate tyrosine residues is an intrinsic property of a very important family of eukaryotic enzymes, the tyrosine kinases [1] . Such phosphorylation permits precise control of various signalling pathways, not only by allowing the activation or inhibition of certain target proteins, but also by promoting interaction between different components of the pathways. Thus, tyrosine kinases are actively involved in the regulation of cellular metabolism, differentiation, adhesion, migration, proliferation and apoptosis [2] . In a normal quiescent cell, the activity of tyrosine kinases is relatively low and very tightly regulated, but is often increased in disease states.
Metal ions are essential components of many biological systems, and play a crucial role in many enzyme reactions [3] . The octapeptide hormone cholecystokinin (CCK 8 ), which occurs naturally in both sulphated and unsulphated forms, has been utilized as a model to investigate the effect of tyrosine phosphorylation or sulphation on metal ion binding [4] . Tyrosine modification increased the stoichiometry of Fe 3+ ion binding from 1 to 2, without greatly affecting the affinity (0.6-2.8 µM at pH 6.5), as measured by changes in absorbance and fluorescence emission. Binding of Ca 2+ , Zn 2+ or Bi
3+
ions to tyrosine phosphorylated-CCK 8 did not cause any change in absorbance, but substantially increased the change in absorbance on subsequent addition of Fe 3+ ions. These results demonstrated that tyrosine modification might increase the affinity of metal ions for peptides, and implied that metal ions might directly regulate many signalling pathways.
In a subsequent study the effect on metal binding of phosphorylation of neighbouring Thr 14 and Tyr 15 residues in synthetic peptides based on the N-terminal sequence of the cyclin-dependent kinase 2 (CDK2) was investigated [5] . Although binding of Fe 3+ ions to the un-phosphorylated peptide was not detected, both of the singly-phosphorylated peptides and the doubly-phosphorylated peptide bound two Fe 3+ ions. The observation that several iron-selective chelators reduced CDK2 activity in HEK293 cells suggested that iron binding might well be necessary for CDK2 activity in vivo [6] .
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The tyrosine kinase c-Src, originally identified by its close homology to the oncogene of the Rous avian sarcoma virus, is the prototype of the Src-family tyrosine kinases (SFKs), which play critical roles in intracellular signalling [7] [8] [9] . For example, the related tyrosine kinase Lyn is expressed in neural tissue, myeloid cells and B lymphocytes, in which it is a key mediator of cell activation [10] .
The activity of Src family members is controlled by modification of a C-terminal tyrosine (Y  530 in human c-Src, Y 508 in human Lyn and Y 522 in human Hck (Figure 1) ) which, when phosphorylated, binds to the SH2 domain at the N-terminus of the same molecule to stabilise the inactive conformation of the kinase domain [11, 12] . The interactions between phosphotyrosine-containing peptides and metal ions described above suggested the possibility that binding of Fe 3+ ions to phosphorylated Y 530 of Src might disrupt the intramolecular interaction with the SH2 domain and hence enhance Src kinase activity.
In this study, the hypothesis that Fe 3+ ions bind to and activate SFKs has been tested by both biophysical and biochemical approaches. Binding of Fe 3+ ions to synthetic peptides derived from the Cterminal regulatory region of SFKs was measured by absorption and NMR spectroscopy. The effect of Fe 3+ ions on the structure and activity of Lyn and Hck, in both the active unphosphorylated conformation and the inactive conformation stabilized by constitutive phosphorylation of the Cterminal regulatory tyrosine, was measured by surface plasmon resonance and by in vitro kinase assay. as described previously [13, 14] . The purity of all peptides was >95% as assessed by reverse phase HPLC.
Absorption spectroscopy.
Absorption spectra of peptides (40 M in 10 mM Na acetate (pH 4.0) or 10 mM Na PIPES (pH 6.5) containing 100 mM NaCl and 0.005% Tween 20) in the presence of increasing concentrations of ferric ions were measured against a buffer blank, in 1 ml quartz cuvettes thermostatted at 298 K, with a Cary 5 spectrophotometer (Varian, Mulgrave, Australia). Data (expressed as means ± S.E.M.) for the independent binding of ferric ions to peptides were fitted to one-site or two-site ordered models with the program BioEqs [15, 16] . ].
Preparation of Lyn or Hck kinase.
Recombinant mouse Lyn or Hck kinase stoichiometrically phosphorylated at the C-terminal regulatory tyrosine (Y 508 for Lyn, Y 522 for Hck) was generated by co-expression with the recombinant C-terminal Src Kinase CSK in Sf9 cells as described in our previous reports [19, 20] . Briefly, Sf9 cells (1L, 0.7×10 6 -1×10 6 cells/ml) were co-infected with recombinant Lyn or Hck baculovirus and CSK baculovirus at a multiplicity of infection ≥ 2. The cells were harvested 50 h after infection, and the recombinant Lyn [19] or Hck [20] was purified to ≥ 90% purity by sequential chromatography on [19] . Briefly, the enzyme preparations were applied to a pYEEI-gel column (1 ml packed volume, loading density = 0.85 µmol of pYEEI peptide per ml of packed gel) pre-equilibrated with the affinity column buffer (25 mM Hepes pH 7.0, 0.1% NP-40, 10% glycerol, 1 mM EDTA, 0.2 mg/ml Baldwin 7 benzamidine, 10 mM β-glycerophosphate, 0.1 mg/ml PMSF, 1 mM DTT, 0.5 mM Na 3 VO 4 and 50 mM NaF [24, 25] . A blank channel was also derivatized using the same conditions to serve as a control.
Prior to biosensor analysis, proteins were purified using micropreparative size exclusion chromatography with a Superose 12 column (PC 3.2/30) equilibrated in HBS and connected to a SMART system (GE Healthcare) [24, 25] . Proteins were quantified by UV spectroscopy using their molecular extinction coefficient at 280 nm calculated from their amino acid composition (http://au.expasy.org/tools/protparam.html). Samples for analysis (90 μl) were injected over the sensor surface at a flow rate of 30 μl/min to minimize mass transport of analyte to the immobilized peptide.
All sensorgrams were corrected by subtraction of the corresponding signal obtained when the sample was injected over a derivatised control channel. Following completion of the injection phase, the dissociation was monitored in HBS for 180s at the same flow rate. The flow channel was regenerated with glycine (10mM; pH 2.0) prior to the next injection cycle.
Binding curves were measured quantitatively for kinetic constants using BIAEVALUATION 4.1 software. All sensorgrams were fitted with a 1/1 Langmuir model using the regions of the dissociation and association phases where Langmuir interactions appeared to be operative. Equilibrium dissociation Baldwin 9 constants (K D ) were obtained from values of k a (association rate, linear with respect to plots of ln dR/dt versus t)) and k d (dissociation rate, fitted in the linear region for plots of ln (R o /R) versus t). The goodness of fit between experimental data and fitted curves were estimated by chi-squared (χ 2 ) analysis using the equation:
where r f is the fitted value at a given point, r x is the experimental value at the same point, n is the number of data points and p is the number of degrees of freedom. To enable a comparison of the surface reactivity following the different immobilisation chemistries, the molar binding activities were calculated from the equation:
Molar binding activity = (enzyme response) × (peptide molecular weight) (amount of immobilised peptide) × (enzyme molecular weight)
Statistics.
Data from the lyn and hck kinase assays were analysed by one-way ANOVA with Bonferroni correction with the program Sigmastat (Jandel Scientific, San Raphael, CA).
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3. Results
Phosphorylation enhances the binding of ferric ions to Src C-terminal tail peptides.
The effect of addition of Fe 3+ ions on the absorption spectrum of the Src C-terminal peptides Table 1 , gave good fits to the absorbance data for all three peptides. The c-Src C-terminal tail peptide bound two Fe 3+ ions with affinities of 33 and 252 M, and phosphorylation increased the affinities at least 10-fold to 1.4 and 23
M.
To assess the contribution of ionization of the phosphorylated tyrosine residue to ferric ion binding, the titration experiments were repeated at pH 6.5, as the pKa of the phosphoryl group of phosphotyrosine is 5.9 [26] . At pH 6.5, no precipitation of iron hydroxides was observed during the course of the experiment. The observation that the absorbance did not change greatly on addition of ferric ions up to a molar ratio of 1:1 suggests that binding of the first ferric ion did not cause a major change in absorbance at this pH ( Figure 2B ). A two-site model, with the dissociation constants given in Table 1 , again gave good fits to the absorbance data for all three peptides. At pH 6.5, phosphorylation had little effect on the affinities of the Src C-terminal peptide for Fe 3+ ions.
NMR Spectroscopy.
In an attempt to define the ligands involved in ferric ion binding, the effect of ferric ions on the Figure 3D ). In particular there was a small downfield shift in the NH triplet of the sole glycine residue, to a maximum of 0.02 ppm at 10 mol/mol of added Fe 3+ ion. As previously observed with Fe 3+ ion binding to pY-CCK 8 [4] , the absence of any significant movement or reduction in the glutamate side chain resonances was consistent with a distant interaction with the metal ion, presumably via the phosphate group, rather than with direct ligation.
Effect of other metal ions on binding of ferric ions to pY 530 -SrcC.
To ascertain the specificity of ferric ion binding to pY 530 Figure 4A-C) or at pH 6.5 ( Figure 4D-F) . With added Ca 2+ ( Figure 4D) or Zn 2+ ( Figure 4E ), subsequent addition of ferric ions at pH 6.5 did not cause a substantially greater increase in absorption than the increase observed in the presence of ferric ions alone. In contrast, with added Bi 3+ at pH 6.5, the increase in absorption on addition of ferric ions was well fitted by a one-site model ( Figure 4F ). The data are consistent with the conclusions that Bi 3+ ions compete effectively with one of the two ferric ion binding sites, that the Bi 3+ ion is bound more tightly than the Fe 3+ ion, and that binding of the Bi 3+ ion has no effect on peptide absorption.
Binding of ferric ions to Lyn peptides.
The binding of Fe 3+ ions to the corresponding tyrosine-phosphorylated C-terminal peptide from the tyrosine kinase Lyn (pY 508 -LynC, Figure 1 ) was then examined. At pH 4.0 the absorbance of pY 508 -LynC at 275 nm increased on addition of Fe 3+ ions; this increase was greater, and occurred at lower ratios of ferric ion to peptide, than with pY 530 -SrcC ( Figure 5A ). A two-site model, with the dissociation constants given in Table 1 , again gave good fits to the absorbance data, although the K d values were much lower (1.2 pM and 160 nM), and the absorbance values greater, than the corresponding values for the Src peptide.
The binding of Fe 3+ ions to pY 508 -LynC at pH 6.5 was more difficult to interpret. The increase in absorbance at 275 nm was again greater than with pY 530 -SrcC, but a decrease in absorbance was observed at higher ratios of ferric ion to peptide ( Figure 5B ). Since no precipitation was visible, one possible explanation is that a third binding site for Fe 3+ ions exists at the higher pH, but in fact a threesite model gave a worse fit to the data than a two-site model.
Ferric ions stimulate the kinase activity of Lyn and Hck stoichiometrically phosphorylated at
the C-terminal regulatory tyrosine.
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Since Addition of ferric ions enhanced the activity of pY 508 -Lyn ( Figure 6C ). thereby increasing the open and active conformation of Lyn, a similar increase was observed with unphosphorylated Lyn (data not shown).
Among the Src-family members, Lyn exhibits the highest degree of sequence homology to Hck.
For example, the sequences of the C-terminal segments of Lyn and Hck differ only by one residueGly-506 of Lyn is replaced by Ser-520 at the homologous position in Hck. This high degree of sequence homology prompted us to examine the effect of ferric ions on the kinase activity of Hck with its C-terminal tail tyrosine (Tyr-522) stoichiometrically phosphorylated (pY 522 -Hck) ( Figure 7A ).
Similar to the effect on pY 508 -Lyn, ferric ions induce a significant increase in kinase activity of pY 522 -Hck ( Figure 7B ). For example, the activity of pY 522 -Hck was increased by 560% by the addition of 80 µM of ferric ions.
In contrast, the activity of the unphosphorylated forms of Lyn ( Figure 6D ) and Hck ( Figure 7B) in the presence of 80 M ferric ions was reduced by 59% and 34%, respectively One possible explanation for the observed decrease in the activity of the unphosphorylated enzymes is that Fe 3+ ions may compete for the Mg 2+ binding site of ATP and hence reduce the amount of Mg-ATP available for the kinase reaction. This notion is further supported by our observation that increasing concentrations of ferric ions reduce the activity of the isolated kinase domain of Hck, by over 50% at a ferric ion concentration of 80 M (Supplementary Fig. S1 ). Since the isolated kinase domain of Hck lacks the phosphorylated C-terminal tail tyrosine to which the ferric ions can bind, the effect of ferric ions on the kinase activity can only be exerted directly on the kinase domain, presumably by reducing the amount of Mg 2+ -ATP. Because of the likely confounding effect on activity of the binding of Fe 3+ ions to the Mg 2+ binding site of ATP, no attempt was made to determine in more detail the effect of Fe 3+ ions on the kinetic parameters of the kinase reaction for the phosphorylated forms of Lyn or Hck.
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Discussion
The data presented in this paper indicate that peptides derived from the C-terminus of the tyrosine kinase Src bind metal ions. The unmodified SrcC peptide binds two Fe 3+ ions with affinities of 33 and 252 M, and tyrosine phosphorylation increases the affinities by more than 10-fold to 1.4 and 23 M.
The selective precipitation of the pY 530 -SrcC peptide observed in NMR experiments at pH 4.0 is also consistent with our previous conclusion [4, 5] The data presented herein also support the hypothesis that kinases of the Src family may be regulated by metal ions in vitro. The activity of Src family members is controlled by modification of the C-terminal regulatory tyrosine (referred to as Y T ) ( Figure 8A ) which, when phosphorylated, binds to the SH2 domain at the N-terminus of the same molecule with consequent disruption of the active site [11, 12] . The interactions between the pY 530 -SrcC peptide and metal ions described above are consistent with the suggestion that binding of Fe 3+ ions to the phosphorylated Y T of Src might disrupt the intramolecular interaction with the SH2 domain and hence enhance kinase activity ( Figure 8B ). The kinase activity of purified preparations of the phosphorylated forms of Lyn ( Figure 6C ) or Hck ( Figure   7B ) in the presence of ferric ions showed a 250 or 560% enhancement, respectively. In contrast the activity of the purified unphosphorylated form of Lyn ( Figure 6D ) or Hck ( Figure 7B ) in the presence of ferric ions was reduced by 59 or 34%, respectively, presumably because of binding of Fe 3+ ions to Baldwin 16 the Mg 2+ binding site of ATP [27] . Thus, the actual effect of the interaction between Fe 3+ ions on the activity of the phosphorylated form of Lyn or Hck may well be greater, because competition for ATP by Fe 3+ ions would be expected to reduce activity simultaneously. Because the activity of the unphosphorylated forms of Lyn and Hck is substantially higher than the activity of the corresponding phosphorylated form, it may be argued that the effect of ferric ions on the total Lyn (or Hck) activity will be minimal. However the critical question here is the relative amount of Lyn (or Hck) in the less active phosphorylated form. It is well established that in normal cells, the majority of SFKs such as Src,
Hck and Lyn are kept in the inactive state by phosphorylation of the conserved C-terminal tail tyrosine [28] . Thus, binding of ferric ions will have a substantial effect on total activity. Relevant to this, we previously discovered that the specific activity of the SFK member Src in breast cancer cells is 2-5.6-fold higher than that of Src expressed in normal fibroblasts. Furthermore, Muthuswamy, et al. found that the specific activity of Src in mammary tumour is ~6.7-fold higher than that of Src expressed in the adjacent mammary epithelium. Since Src protein molecules in normal fibroblasts and epithelial cells are mostly kept in the closed inactive conformation (Fig. 8A) , the 2-6.7-fold increase in Src specific activity is sufficient to contribute to tumorigenicity of breast cancer. Thus, our finding that ferric ions could increase the activity of pY 508 -Lyn and pY 522 -Hck by 2.5-6.6 folds is in agreement with the level of SFKs in cancer cells. It also implies that the activation of SFKs by ferric ions can have potential physiological impacts.
Little evidence exists in the literature for or against the hypothesis that kinases of the Src family are regulated by metal ions in vivo. On the one hand, in patients with the iron overload disease hereditary haemochromatosis, the tyrosine kinase activity of the CD8-associated Lck was significantly reduced compared to healthy controls [29] . On the other hand, in a subsequent in vitro study by the same authors, treatment of peripheral blood T-lymphocytes with ferric citrate reduced the amount of Lck associated with CD4, with a consequent decrease in the kinase activity of the CD4-associated Lck, Baldwin 17 but had no effect on the kinase activity of the CD8-associated Lck [30] . The concentration of the labile iron pool in lymphocytes from healthy humans is 0.57 ± 0.27 M [31] , and in cultured rat hepatocytes 5.4 ± 1.3 M [32] . Hence the concentration of the labile iron pool in lymphocytes from iron-overloaded individuals may well reach sufficiently high values to affect Lyn activity ( Figure 6C ).
SFKs may in some cases be involved in iron homeostasis. Drakesmith and coworkers have reported that down-regulation of the hemochromatosis protein HFE by the HIV-1 accessory protein
Nef is responsible for the accumulation of iron in HIV-1-infected macrophages [33] . Furthermore, this effect of Nef requires the PxxP motif, which binds to the SH3 domain of Hck and Lyn to induce their activation [34] . Since Hck and Lyn are expressed in macrophages and participate in macrophage functions such as phagocytosis, it is likely that the Nef-activated Hck and/or Lyn contribute to downregulation of HFE in the infected macrophages. Given that Fe 3+ ions can directly bind to the phosphorylated C-terminal tyrosine to induce activation of Hck and Lyn (Figures 6 and 7) , it is possible that both Nef and the high concentration of Fe 3+ ions cooperate to cause aberrant activation of Hck and/or Lyn in HIV-1-infected macrophages.
Iron uptake into neurons can stimulate generation of reactive oxygen species (ROS) and in turn modify the intracellular concentrations of reduced and oxidized glutathione [35] . In addition, iron uptake also leads to an increase in the labile iron pool in neurons [36] . Reactive oxygen species have been reported to activate the Src-family member Src by oxidation of Cys 245 and/or Cys 487 [37] . In contrast a recent report indicates that some SFKs may be inactivated by oxidation of Cys 280 [38] .
Formation of a disulfide bridge results in homodimerisation and up to a 90% loss of activity. The results presented in Figures 6 and 7 suggest an alternative mechanism, independent of reactive oxygen species, by which ferric ions may control the activity of the Src-family kinases Lyn and Hck.
In summary, the data presented herein establish that peptides derived from the C-terminus of the tyrosine kinases Src and Lyn bind Fe 3+ ions, and that binding to the Src peptide at pH 4.0 is enhanced Baldwin 18 by phosphorylation of Y 530 . The observation that the kinase activity of the phosphorylated forms of Lyn or Hck is significantly greater in the presence of Fe 3+ ions than in their absence is consistent with the hypothesis that binding of Fe 3+ ions to the phosphorylated C-terminal tyrosine of SFKs disrupts the intramolecular interaction with the SH2 domain and hence enhances kinase activity. These observations lay the biochemical foundation for future investigation of the regulation of Src family kinases by metal ions. Moreover our discoveries suggest that the intracellular effects of Fe 3+ ions may be mediated by direct activation of signalling pathways as well as by the generation of reactive oxygen species.
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Figure legends The affinity of ferric ion binding to 
